Date of Record:  May 20, 2022

CDC has updated its guidance for COVID-19 vaccination, including:

• New guidance for use of a Pfizer-BioNTech COVID-19 Vaccine booster dose in children ages 5–11 years
  
  
• Updated guidance that the following people should receive a second COVID-19 booster dose
  • People ages 12 years and older who are moderately or severely immunocompromised
  • People ages 50 years and older
• Updated guidance for people who are moderately or severely immunocompromised and are treated with B-cell-depleting therapies
  
  
• Updated guidance for primary series vaccination after SARS-CoV-2 infection
  
  
• Clarification of COVID-19 vaccination guidance for multisystem inflammatory syndrome in children (MIS-C) and adults (MIS-A)

To view all updates, please visit CDC’s Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States.